Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma

References

• SwerdlowAJEpidemiology of testicular cancerRaghavenDScherHLeibelSLangePPrinciples and Practice of Genitourinary Oncology1st edPhiladelphia, PA, USALippincott Williams & Wilkins1997
   Google Scholar
• ChooRThomasGWooTLong-term outcome of postorchiectomy surveillance for stage I testicular seminomaInt J Radiat Oncol Biol Phys20056173674015708251
   PubMed Web of Science ®Google Scholar
• WardePSpechtLHorwichAPrognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysisJ Clin Oncol2002204448445212431967
   PubMed Web of Science ®Google Scholar
• FossaSDHorwichARussellJMOptimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working GroupJ Clin Oncol199917114610561173
   PubMed Web of Science ®Google Scholar
• MirimanoffRORadiotherapy of testicular seminoma: changes over the past 10 yearsCancer Radiother20037Suppl 170s77s15124547
   PubMedGoogle Scholar
• ScholzMHoltlWStage I testicular cancerCurr Opin Urol20031347347614560141
   PubMed Web of Science ®Google Scholar
• WardePJewettMASurveillance for stage I testicular seminoma. Is it a good option?Urol Clin North Am1998254254339728212
   PubMed Web of Science ®Google Scholar
• JonesWGFossaSDMeadGMRandomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)J Clin Oncol2005231200120815718317
   PubMed Web of Science ®Google Scholar
• ZagarsGKBalloMTLeeAKMortality after cure of testicular seminomaJ Clin Oncol20042264064714726503
   PubMed Web of Science ®Google Scholar
• TravisLBCurtisREStormHRisk of second malignant neoplasms among long-term survivors of testicular cancerJ Natl Cancer Inst199789142914399326912
   PubMed Web of Science ®Google Scholar
• HorwichAAlsanjariNA’HernRSurveillance following orchidectomy for stage I testicular seminomaBr J Cancer1992657757781586607
   PubMed Web of Science ®Google Scholar
• von der MaaseHSpechtLJacobsenGKSurveillance following orchidectomy for stage I seminoma of the testisEur J Cancer199329A193119348280484
   PubMed Web of Science ®Google Scholar
• WardePGospodarowiczMKBanerjeeDPrognostic factors for relapse in stage I testicular seminoma treated with surveillanceJ Urol1997157170517109112510
   PubMed Web of Science ®Google Scholar
• OliverRTEdmondsPMOngJYPilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?Int J Radiat Oncol Biol Phys199429388175442
   PubMed Web of Science ®Google Scholar
• OliverRTMeadGMRustinGJRandomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 studyJ Clin Oncol20112995796221282539
   PubMed Web of Science ®Google Scholar
• PatriceSJPatriceJRSteinbergJSA cost-effectiveness analysis of surveillance, radiotherapy, and carboplatin in the management of stage I testicular seminomaJ Clin Oncol20062418S6108
   Google Scholar
• ShardaNNKinsellaTJRitterMAAdjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminomaJ Clin Oncol199614293329398918490
   PubMed Web of Science ®Google Scholar
• KollmannsbergerCTandstadTBedardPPatterns of relapse in patients with clinical stage I testicular cancer managed with active surveillanceJ Clin Oncol8182014 Epub ahead of print
   Google Scholar
• ArvoldNDCatalanoPJSweemeuCJBarriers to the implementation of surveillance for stage I testicular seminomaInt J Radiat Oncol Biol Phys20128438833889
   Web of Science ®Google Scholar
• ClassenJSchmidbergerHMeisnerCRadiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trialJ Clin Oncol2003211101110612637477
   PubMed Web of Science ®Google Scholar
• ChungPWGospodarowiczMKPanzarellaTStage II testicular seminoma: patterns of recurrence and outcome of treatmentEur Urol20044575475915149748
   PubMed Web of Science ®Google Scholar
• Garcia-del-MuroXMarotoPGumaJChemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group StudyJ Clin Oncol2008265416542118936476
   PubMed Web of Science ®Google Scholar
• KregeSBoergermannCBaschekRSingle agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG)Ann Oncol20061727628016254023
   PubMed Web of Science ®Google Scholar
• KollmannsbergerCTyldesleySMooreCEvolution in management of testicular seminoma: Population-based outcomes with selective utilization of active therapiesAnn Oncol20112280881420926549
   PubMed Web of Science ®Google Scholar
• ChungPWDaugaardGTyldesleyPrognostic factors for relapse in stage I seminoma with surveillance: a validation studyJ Clin Oncol201028 Abstr 4535
   Web of Science ®Google Scholar
• ChungPWardePStage I seminoma: adjuvant treatment is effective but is it necessary?J Natl Cancer Inst201110319419621212383
   PubMedGoogle Scholar
• BachaudJMBerthierFSoulieMSecond non-germ cell malignancies in patients treated for stage I–II testicular seminomaRadiother Oncol19995019119710368043
   PubMed Web of Science ®Google Scholar
• ChaoCKLaiPPMichalskiJMSecond malignancy among seminoma patients treated with adjuvant radiation therapyInt J Radiat Oncol Biol Phys1995338318357591890
   PubMed Web of Science ®Google Scholar
• GlanzmannCSchultzGLutolfUMLong-term morbidity of adjuvant infradiaphragmatic irradiation in patients with testicular cancer and implications for the treatment of stage I seminomaRadiother Oncol19912212181947208
   PubMed Web of Science ®Google Scholar
• RutherUDieckmannKPBussar-MaatzRSecond malignancies following pure seminomaOncology200058758210644944
   PubMed Web of Science ®Google Scholar
• van LeeuwenFEStiggelboutAMvan den Belt-DuseboutAWSecond cancer risk following testicular cancers: a follow-up study of 1,909 patientsJ Clin Oncol2003211513152312697875
   PubMed Web of Science ®Google Scholar
• Jonker-PoolGvan BastenJPHoekstraHJSexual functioning after treatment for testicular cancer: comparison of treatment modalitiesCancer1997804544649241079
   PubMed Web of Science ®Google Scholar
• van den Belt-DuseboutAWde WitRGietemaJATreatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancerJ Clin Oncol2007254370437817906202
   PubMed Web of Science ®Google Scholar
• TarinTVSonnGShinghalREstimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomographyJ Urol200918162763219091344
   PubMed Web of Science ®Google Scholar
• PandharipandePVEisenbergJDLeeRJPatients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradoxRadiology201326689690423249573
   PubMed Web of Science ®Google Scholar
• National Research CouncilAdvisory Committee on the Biological Effects of Ionizing Radiation Health risks from exposure to low levels of ionizing radiationBEIR VII Phase 2 Washington, DC, USANational Academy of Sciences2006 Available from: http://www.nap.edu/openbook.php?isbn=030909156XAccessed November 4, 2014
   Google Scholar